Philogen S.p.A. announced that they have entered into a collaboration, option and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover and develop a new class of immunomodulatory therapeutics.
PHILOGEN ANNOUNCED COLLABORATION WITH JOHNSON & JOHNSON INNOVATION.